Crossref
Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply
JAMA · 03.11.2026 · 336 (17) · 1568
DOI: 10.1001/jama.2026.16113 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 03.11.2026. Verfasst von Sunil V Badve und 2 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Renal Medicine, St George Hospital, Sydney, New South Wales, Australia.
- Division of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge, Brugge, Belgium.
- Department of Internal Medicine, Ghent University, Ghent, Belgium.
- University of New South Wales, Sydney, New South Wales, Australia.
Zitieren
APA
Badve, S. V., De Vriese, A. S., & Gallagher, M. (2026). Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply. JAMA, 336(17), 1568. https://doi.org/10.1001/jama.2026.16113
Vancouver
Badve SV, De Vriese AS, Gallagher M. Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply. JAMA. 2026;336(17):1568. doi:10.1001/jama.2026.16113
BibTeX
@article{Badve2026,
author = {Badve, Sunil V and De Vriese, An S and Gallagher, Martin},
title = {Low-Dose Rivaroxaban, Cardiovascular Events, and Kidney Disease—Reply},
journal = {JAMA},
year = {2026},
volume = {336},
number = {17},
pages = {1568},
doi = {10.1001/jama.2026.16113}
}
EUVIMED